We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel.
- Authors
Sessa, C; Tosi, D; Viganò, L; Albanell, J; Hess, D; Maur, M; Cresta, S; Locatelli, A; Angst, R; Rojo, F; Coceani, N; Rivera, V M; Berk, L; Haluska, F; Gianni, L
- Abstract
The additive cytotoxicity in vitro prompted a clinical study evaluating the non-prodrug rapamycin analogue ridaforolimus (AP23573; MK-8669; formerly deforolimus) administered i.v. combined with paclitaxel (PTX; Taxol).
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Vol 21, Issue 6, p1315
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdp504